Press "Enter" to skip to content

Eli Lilly’s Alzheimer’s drug gets backing from FDA advisers

https://www.marketwatch.com/story/eli-lillys-alzheimers-drug-gets-backing-from-fda-advisers-b094f0c9?mod=mw_rss_topstories
Eli Lilly’s experimental Alzheimer’s drug donanemab on Monday moved a step closer to U.S. regulatory approval as it won support from an independent panel of advisers to the Food and Drug Administration…

More from BusinessMore posts in Business »
More from UncategorizedMore posts in Uncategorized »